ShareHope Medicine Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	4,358	4,326	3,873	4,137	3,850
Revenue Growth (YoY)	0.74%	11.68%	-6.38%	7.46%	-6.07%
Cost of Revenue	3,649	3,611	3,147	3,153	3,016
Gross Profit	709.01	714.4	726.38	983.91	833.96
Selling, General & Admin	618.16	727.54	697.17	718	664.41
Research & Development	5.62	11.82	12.3	16.4	-
Other Operating Expenses	-77.75	-78.51	-80.88	-77.84	-69.2
Operating Expenses	550.45	671.79	631.69	654.53	579.7
Operating Income	158.56	42.61	94.69	329.38	254.26
Interest Expense	-47.81	-57.39	-53.64	-38.12	-20.1
Interest & Investment Income	16.47	57.61	10.26	6.06	5.1
Earnings From Equity Investments	-1.23	0.44	-1.85	-0.4	-0.22
Currency Exchange Gain (Loss)	-0.56	2.81	0.9	10.95	-4.17
Other Non Operating Income (Expenses)	16.04	24.33	24.41	70.85	15.63
EBT Excluding Unusual Items	141.48	70.4	74.77	378.7	250.5
Gain (Loss) on Sale of Investments	-3.63	9.28	8.89	2.96	38.59
Gain (Loss) on Sale of Assets	4.53	135.64	23.91	9.13	3.71
Asset Writedown	-1.26	-41.65	0.92	-51.47	-25.65
Other Unusual Items	9.02	0.24	0.5	0.6	0.48
Pretax Income	150.15	173.91	108.98	339.94	267.63
Income Tax Expense	38.25	51.51	53.72	95.83	74.2
Earnings From Continuing Operations	111.9	122.4	55.27	244.11	193.43
Minority Interest in Earnings	29.83	77.7	69.29	49.84	39.24
Net Income	141.73	200.1	124.56	293.95	232.66
Net Income to Common	141.73	200.1	124.56	293.95	232.66
Net Income Growth	-29.17%	60.65%	-57.63%	26.34%	-6.08%
Shares Outstanding (Basic)	138	138	138	138	138
Shares Outstanding (Diluted)	138	138	138	139	139
Shares Change (YoY)	-0.02%	0.03%	-0.26%	-0.28%	-1.83%
EPS (Basic)	1.03	1.45	0.90	2.14	1.69
EPS (Diluted)	1.03	1.45	0.90	2.12	1.68
EPS Growth	-28.99%	60.26%	-57.41%	26.73%	-4.75%
Free Cash Flow	240.15	183.6	6.83	-623.51	222.59
Free Cash Flow Per Share	1.74	1.33	0.05	-4.50	1.60
Dividend Per Share	-	0.500	0.366	0.436	0.415
Dividend Growth	-	36.50%	-16.01%	5.01%	5.01%
Gross Margin	16.27%	16.52%	18.75%	23.78%	21.66%
Operating Margin	3.64%	0.98%	2.44%	7.96%	6.60%
Profit Margin	3.25%	4.63%	3.22%	7.11%	6.04%
Free Cash Flow Margin	5.51%	4.24%	0.18%	-15.07%	5.78%
EBITDA	355.09	268.82	276.12	499.51	435.05
EBITDA Margin	8.15%	6.21%	7.13%	12.07%	11.30%
D&A For EBITDA	196.53	226.21	181.43	170.13	180.79
EBIT	158.56	42.61	94.69	329.38	254.26
EBIT Margin	3.64%	0.98%	2.44%	7.96%	6.60%
Effective Tax Rate	25.48%	29.62%	49.29%	28.19%	27.73%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.